Ivana Sokol

Dr. Ivana Sokol

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2025 in RSC Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
ISIvana Sokol
Ivana Sokol
ARAnja Rakas
Anja Rakas
DGDajana Kučić Grgić
Dajana Kučić Grgić
LPLeentje Persoons
Leentje Persoons
DDDirk Daelemans
Dirk Daelemans
TKTatjana Gazivoda Kraljević
Tatjana Gazivoda Kraljević
This paper describes ultrasound synthesis, structural characterization and biological activity of new derivatives of 2-arylbenzimidazole 12–27 and 1,2,3-triazole derivatives of 2-arylbenzimidazole 28–33. The tautomeric structures of the prepared target compounds were confirmed by 1H- and 13C-NMR spectroscopy as well as by two-dimensional NOESY, HSQC and HMBC methods. The synthesized compounds underwent in vitro antiproliferative assays, revealing that compound 23 exhibited the highest potency against chronic myeloid leukemia cells (K-562, IC50 = 2.0 μM) and non-Hodgkin's lymphoma cells (Z-138, IC50 = 2.0 μM). Compound 23 was further evaluated for cytotoxicity on normal peripheral blood mononuclear cells (PBMC), and its mechanism of action was investigated. The antibacterial properties of the synthesized compounds were assessed against both Gram-positive and Gram-negative bacterial strains. Derivatives 15–17 exhibited significant selective antibacterial activity against the Gram-positive bacterium Enterococcus faecalis (MIC = 0.25–1 μg mL−1). Additionally, among the 1,2,3-triazole derivatives of 2-arylbenzimidazole, compounds 28 and 30 demonstrated strong selective activity against Enterococcus faecalis (MIC = 0.25 μg mL−1).

3 November 2025 in Sustainable Chemistry
Verified
Journal Article
Open access
PDF file
ISIvana Sokol
Ivana Sokol
HMHanja Mlinar
Hanja Mlinar
Dajana Kučić GrgićDajana Kučić Grgić
Dajana Kučić Grgić
LPLeentje Persoons
Leentje Persoons
DDDirk Daelemans
Dirk Daelemans
TKTatjana Gazivoda Kraljević
Tatjana Gazivoda Kraljević
This study reports the solvent-free mechanochemical synthesis of a novel series of 2-hydrazone-bridged benzothiazole derivatives 19–52 via the reaction of 2-hydrazinylbenzothiazole derivatives 4–6 with O-alkylated benzaldehydes 7–18. The stereostructure of the E-isomers was confirmed by 2D NOESY spectroscopy. The antiproliferative potential of these newly prepared 2-hydrazone derivatives of benzothiazole 19–52 was evaluated in vitro against eight human cancer cell lines. Several compounds demonstrated low micromolar IC50 values, with some outperforming the reference drug etoposide. Among the most potent compounds, the 6-chloro-2-hydrazone(3-fluorophenyl)benzothiazole derivative 38 exhibited remarkable activity against pancreatic adenocarcinoma (Capan-1, IC50 = 0.6 µM) and non-small cell lung cancer (NCI-H460, IC50 = 0.9 µM). Structure–activity relationship analysis revealed that derivatives 45–52, featuring a methoxy group at position 6 of the benzothiazole ring and either a methoxy or fluorine substituent at position 3 of the phenyl ring, showed consistently strong antiproliferative effects across all tested cell lines (IC50 = 1.3–12.8 µM). Furthermore, compounds bearing N,N-diethylamino or N,N-dimethylamino groups at position 4 of the phenyl ring generally exhibited superior activity compared to those with morpholine or piperidine moieties. However, as this study represents an initial screening, further mechanistic investigations are required to confirm specific anticancer pathways and therapeutic relevance. In addition to their in vitro anticancer properties, the antibacterial activity of the compounds was assessed against both Gram-positive and Gram-negative bacteria. Notably, compound 37 demonstrated selective antibacterial activity against Pseudomonas aeruginosa (MIC = 4 µg/mL). Overall, this work highlights the efficiency of a green, mechanochemical approach for synthesizing E-isomer hydrazone-bridged benzothiazoles and underscores their potential as promising scaffolds for the development of potent antiproliferative agents.